FULGENT GENETICS INC (FLGT) Fundamental Analysis & Valuation

NASDAQ:FLGT • US3596641098

Current stock price

15.59 USD
-0.78 (-4.76%)
At close:
15.59 USD
0 (0%)
After Hours:

This FLGT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. FLGT Profitability Analysis

1.1 Basic Checks

  • FLGT had positive earnings in the past year.
  • FLGT had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: FLGT reported negative net income in multiple years.
  • FLGT had a positive operating cash flow in 4 of the past 5 years.
FLGT Yearly Net Income VS EBIT VS OCF VS FCFFLGT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • FLGT's Return On Assets of -4.99% is on the low side compared to the rest of the industry. FLGT is outperformed by 67.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.44%, FLGT is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
ROA -4.99%
ROE -5.44%
ROIC N/A
ROA(3y)-7.36%
ROA(5y)5.59%
ROE(3y)-7.99%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
FLGT Yearly ROA, ROE, ROICFLGT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

1.3 Margins

  • FLGT has a Gross Margin of 40.56%. This is in the better half of the industry: FLGT outperforms 71.00% of its industry peers.
  • FLGT's Gross Margin has declined in the last couple of years.
  • FLGT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-12.42%
FLGT Yearly Profit, Operating, Gross MarginsFLGT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. FLGT Health Analysis

2.1 Basic Checks

  • FLGT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FLGT has more shares outstanding
  • The number of shares outstanding for FLGT has been increased compared to 5 years ago.
  • Compared to 1 year ago, FLGT has an improved debt to assets ratio.
FLGT Yearly Shares OutstandingFLGT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
FLGT Yearly Total Debt VS Total AssetsFLGT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.97 indicates that FLGT is not in any danger for bankruptcy at the moment.
  • FLGT's Altman-Z score of 3.97 is fine compared to the rest of the industry. FLGT outperforms 77.00% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that FLGT is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.00, FLGT belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.97
ROIC/WACCN/A
WACC9.03%
FLGT Yearly LT Debt VS Equity VS FCFFLGT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • FLGT has a Current Ratio of 6.48. This indicates that FLGT is financially healthy and has no problem in meeting its short term obligations.
  • FLGT has a Current ratio of 6.48. This is amongst the best in the industry. FLGT outperforms 96.00% of its industry peers.
  • A Quick Ratio of 6.48 indicates that FLGT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 6.48, FLGT belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.48
Quick Ratio 6.48
FLGT Yearly Current Assets VS Current LiabilitesFLGT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. FLGT Growth Analysis

3.1 Past

  • The earnings per share for FLGT have decreased strongly by -16.33% in the last year.
  • The earnings per share for FLGT have been decreasing by -45.36% on average. This is quite bad
  • Looking at the last year, FLGT shows a quite strong growth in Revenue. The Revenue has grown by 13.83% in the last year.
  • FLGT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.21% yearly.
EPS 1Y (TTM)-16.33%
EPS 3Y-58.41%
EPS 5Y-45.36%
EPS Q2Q%300%
Revenue 1Y (TTM)13.83%
Revenue growth 3Y-19.52%
Revenue growth 5Y-5.21%
Sales Q2Q%9.34%

3.2 Future

  • The Earnings Per Share is expected to decrease by -67.05% on average over the next years. This is quite bad
  • FLGT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.16% yearly.
EPS Next Y-179.61%
EPS Next 2Y-54.32%
EPS Next 3Y-67.05%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y9.69%
Revenue Next 3Y10.16%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FLGT Yearly Revenue VS EstimatesFLGT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
FLGT Yearly EPS VS EstimatesFLGT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

0

4. FLGT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 38.02 indicates a quite expensive valuation of FLGT.
  • The rest of the industry has a similar Price/Earnings ratio as FLGT.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, FLGT is valued quite expensively.
  • The Forward Price/Earnings Ratio is negative for FLGT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 38.02
Fwd PE N/A
FLGT Price Earnings VS Forward Price EarningsFLGT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLGT Per share dataFLGT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as FLGT's earnings are expected to decrease with -67.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.32%
EPS Next 3Y-67.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FLGT Dividend Analysis

5.1 Amount

  • FLGT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FLGT Fundamentals: All Metrics, Ratios and Statistics

FULGENT GENETICS INC

NASDAQ:FLGT (3/27/2026, 8:18:02 PM)

After market: 15.59 0 (0%)

15.59

-0.78 (-4.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners59.82%
Inst Owner Change12.29%
Ins Owners33.57%
Ins Owner Change3.17%
Market Cap486.88M
Revenue(TTM)322.67M
Net Income(TTM)-60.51M
Analysts80
Price Target24.82 (59.2%)
Short Float %7.5%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.17%
Min EPS beat(2)161.46%
Max EPS beat(2)422.88%
EPS beat(4)4
Avg EPS beat(4)210.74%
Min EPS beat(4)121.2%
Max EPS beat(4)422.88%
EPS beat(8)8
Avg EPS beat(8)189.87%
EPS beat(12)11
Avg EPS beat(12)152.03%
EPS beat(16)15
Avg EPS beat(16)147.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.55%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)1.21%
Revenue beat(4)3
Avg Revenue beat(4)0.81%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)5.24%
Revenue beat(8)4
Avg Revenue beat(8)-0.37%
Revenue beat(12)8
Avg Revenue beat(12)3.89%
Revenue beat(16)12
Avg Revenue beat(16)5.48%
PT rev (1m)-27.72%
PT rev (3m)-27.72%
EPS NQ rev (1m)-97.06%
EPS NQ rev (3m)-97.06%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-16.87%
Revenue NQ rev (3m)-16.87%
Revenue NY rev (1m)-2.26%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE 38.02
Fwd PE N/A
P/S 1.51
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)0.41
EY2.63%
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-3.98
FCFYN/A
OCF(TTM)-3.25
OCFYN/A
SpS10.33
BVpS35.61
TBVpS30.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.12
Profitability
Industry RankSector Rank
ROA -4.99%
ROE -5.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.56%
FCFM N/A
ROA(3y)-7.36%
ROA(5y)5.59%
ROE(3y)-7.99%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-12.42%
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.58%
Cap/Sales 7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.48
Quick Ratio 6.48
Altman-Z 3.97
F-Score5
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)113.42%
Cap/Depr(5y)122.82%
Cap/Sales(3y)9.63%
Cap/Sales(5y)6.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.33%
EPS 3Y-58.41%
EPS 5Y-45.36%
EPS Q2Q%300%
EPS Next Y-179.61%
EPS Next 2Y-54.32%
EPS Next 3Y-67.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.83%
Revenue growth 3Y-19.52%
Revenue growth 5Y-5.21%
Sales Q2Q%9.34%
Revenue Next Year7.26%
Revenue Next 2Y9.69%
Revenue Next 3Y10.16%
Revenue Next 5YN/A
EBIT growth 1Y-23.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.38%
EBIT Next 3Y4.58%
EBIT Next 5YN/A
FCF growth 1Y-545.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-582.61%
OCF growth 3YN/A
OCF growth 5YN/A

FULGENT GENETICS INC / FLGT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for FULGENT GENETICS INC?

ChartMill assigns a fundamental rating of 3 / 10 to FLGT.


Can you provide the valuation status for FULGENT GENETICS INC?

ChartMill assigns a valuation rating of 0 / 10 to FULGENT GENETICS INC (FLGT). This can be considered as Overvalued.


Can you provide the profitability details for FULGENT GENETICS INC?

FULGENT GENETICS INC (FLGT) has a profitability rating of 2 / 10.


Can you provide the financial health for FLGT stock?

The financial health rating of FULGENT GENETICS INC (FLGT) is 6 / 10.


Can you provide the expected EPS growth for FLGT stock?

The Earnings per Share (EPS) of FULGENT GENETICS INC (FLGT) is expected to decline by -179.61% in the next year.